BNP Paribas Arbitrage SA Reduces Stock Position in The Cooper Companies, Inc. (NYSE:COO)

BNP Paribas Arbitrage SA lowered its position in shares of The Cooper Companies, Inc. (NYSE:COO) by 36.2% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 17,005 shares of the medical device company’s stock after selling 9,662 shares during the period. BNP Paribas Arbitrage SA’s holdings in The Cooper Companies were worth $6,739,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently made changes to their positions in COO. Altshuler Shaham Ltd purchased a new stake in The Cooper Companies during the 1st quarter valued at $46,000. CX Institutional raised its holdings in The Cooper Companies by 29.5% in the 2nd quarter. CX Institutional now owns 123 shares of the medical device company’s stock worth $49,000 after purchasing an additional 28 shares in the last quarter. C M Bidwell & Associates Ltd. bought a new position in The Cooper Companies in the 1st quarter worth $118,000. Capital Analysts LLC bought a new position in The Cooper Companies in the 1st quarter worth $129,000. Finally, E Fund Management Co. Ltd. bought a new position in The Cooper Companies in the 1st quarter worth $133,000. 97.08% of the stock is owned by institutional investors and hedge funds.

NYSE:COO opened at $426.75 on Wednesday. The firm has a market cap of $21.04 billion, a P/E ratio of 7.27, a P/E/G ratio of 3.39 and a beta of 0.83. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.83 and a current ratio of 1.39. The Cooper Companies, Inc. has a fifty-two week low of $314.29 and a fifty-two week high of $463.59. The firm has a 50-day simple moving average of $429.74 and a two-hundred day simple moving average of $405.10.

The Cooper Companies (NYSE:COO) last released its quarterly earnings data on Wednesday, September 1st. The medical device company reported $3.41 earnings per share for the quarter, beating analysts’ consensus estimates of $3.29 by $0.12. The business had revenue of $763.40 million during the quarter, compared to analyst estimates of $727.30 million. The Cooper Companies had a net margin of 102.48% and a return on equity of 11.42%. The Cooper Companies’s revenue was up 32.0% compared to the same quarter last year. During the same period last year, the business earned $2.28 EPS. On average, equities research analysts predict that The Cooper Companies, Inc. will post 13.32 EPS for the current year.

The company also recently disclosed a Semi-Annual dividend, which was paid on Wednesday, August 11th. Shareholders of record on Tuesday, July 27th were paid a dividend of $0.03 per share. The ex-dividend date was Monday, July 26th. The Cooper Companies’s dividend payout ratio is currently 0.62%.

COO has been the subject of several research reports. Stifel Nicolaus upped their price objective on shares of The Cooper Companies from $450.00 to $475.00 and gave the stock a “buy” rating in a report on Friday, September 3rd. Piper Sandler upped their price objective on shares of The Cooper Companies from $440.00 to $460.00 and gave the stock an “overweight” rating in a report on Friday, August 6th. Wells Fargo & Company upped their price objective on shares of The Cooper Companies from $445.00 to $480.00 and gave the stock an “overweight” rating in a report on Thursday, August 19th. Citigroup increased their price target on shares of The Cooper Companies from $400.00 to $453.00 and gave the stock a “neutral” rating in a research note on Friday, September 3rd. Finally, Oppenheimer increased their price target on shares of The Cooper Companies from $405.00 to $475.00 and gave the stock an “outperform” rating in a research note on Friday, September 3rd. Two analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat.com, The Cooper Companies currently has an average rating of “Buy” and a consensus price target of $433.08.

In other news, COO Daniel G. Mcbride sold 72,624 shares of the firm’s stock in a transaction dated Tuesday, September 7th. The shares were sold at an average price of $450.13, for a total transaction of $32,690,241.12. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Gary S. Petersmeyer sold 400 shares of the firm’s stock in a transaction dated Monday, July 12th. The shares were sold at an average price of $412.28, for a total transaction of $164,912.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 84,287 shares of company stock valued at $37,722,232. 1.70% of the stock is owned by company insiders.

The Cooper Companies Profile

The Cooper Cos, Inc operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues.

Further Reading: What is the Stochastic Momentum Index (SMI)?

Institutional Ownership by Quarter for The Cooper Companies (NYSE:COO)

Receive News & Ratings for The Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.